ŹRÓDŁA POKARMOWE ORAZ EFEKTY PROZDROWOTNE  SPRZĘŻONYCH DIENÓW KWASU LINOLOWEGO (CLA)

Agnieszka Białek; Andrzej Tokarz

doi:10.56782/pps.61

Published : 2009-01-29

Vol. 7 No. 1 (2009)

DIETARY SOURCES AND BENEFICIAL HEALTH EFFECTS OF CONJUGATED LINOLEIC ACIDS (CLA)

Agnieszka Białek

Andrzej Tokarz

DOI: https://doi.org/10.56782/pps.61

Abstract

Dairy fat is one of the most complex of natural fats. It contains over 400 different fatty acids, most of them (>98%) as triglycerides, and is the main dietary source of conjugated linoleic acids (CLA). CLA is a group of positional and geometric isomers of linoleic acid containing a conjugated double bond system. Rumenic acid (cis-9, trans-11 octadecadienoic acid) is the predominant CLA isomer that accounts for 80–90% of the total CLA amount in dairy fat of poligastric animals. Multiple publications suggest that rational dietetics should assure an adequate supply of CLA, which have many beneficial health effects, including prevention of cancer and diabetes, and antiinflammatory and antiatherogenic properties. Milk and dairy products are the main dietary source of CLA. This review focuses on the health effects of conjugated linoleic acid and also summarizes the CLA content of common dairy products.

Keywords:

conjugated linoleic acid (CLA), dairy products, atherogenesis, tumours

Most read articles by the same author(s)

Małgorzata Idzikowska, Marta Janczura, Tomasz Lepionka, Michał Madej, Edyta Mościcka, Justyna Pyzik, Paulina Siwek, Weronika Szubierajska, Dorota Skrajnowska, Andrzej Tokarz, NANOTECHNOLOGY IN FOOD PRODUCTION – DEVELOPMENT, RISKS AND REGULATORY ASPECTS , Prospects in Pharmaceutical Sciences: Vol. 10 No. 4 (2012)
Katarzyna Czuba, Magdalena Mazurkiewicz, Kamil Kamiński, Filip Różewski, Dorota Skrajnowska, Andrzej Tokarz, BIOTERRORISM – THREAT, PREVENTIVE ACTIONS, INTERNATIONAL LAW , Prospects in Pharmaceutical Sciences: Vol. 9 No. 2 (2011)
Paulina Brewczyńska, Justyna Makowska, Dorota Skrajnowska, Marta Teryks, Andrzej Tokarz, ADDICTION TO CONVENTIONAL AND ELECTRONIC CIGARETTES AND THE RISKS OF PHARMACOTHERAPY IN SMOKERS. , Prospects in Pharmaceutical Sciences: Vol. 13 No. 3 (2015)
Andrzej Tokarz, Małgorzata Jelińska, Agnieszka Ozga, ISOPROSTANES - NEW BIOMARKERS IN LIPID PEROXIDATION IN VIVO , Prospects in Pharmaceutical Sciences: Vol. 2 No. 2 (2004)

Similar Articles

Agnieszka Kalicka, Natalia Tarłowska, Counterfeit and illegal medicinal products as an example of drugs that do not meet the basic quality requirements , Prospects in Pharmaceutical Sciences: Vol. 21 No. 4 (2023)
Paulina Dąbrowska, Michał Żuber, Michał Dacka, Efficacy and safety of bempedoic acid in lipid disorder therapy: a review of clinical trials , Prospects in Pharmaceutical Sciences: Vol. 22 No. 3 (2024)
Łukasz Dobrek, Analysis of the activity of the Polish Office for Registration of Medicinal Products, Medical Devices and Biocidal Products in the field of clinical trials, registration of medicinal products and monitoring of adverse drug reactions in 2017-2021 , Prospects in Pharmaceutical Sciences: Vol. 20 No. 4 (2022)
Tomasz Kordowski, Tomasz Tatara, Adam Fronczak, REVIEW OF CURRENT GUIDELINES AND STUDIES ON USE OF ACETYLSALICYLIC ACID IN THE PRIMARY CARDIOVASCULAR EVENTS PREVENTION , Prospects in Pharmaceutical Sciences: Vol. 17 No. 4 (2019)
Katarzyna Herjan, Piotr Armański, Jakub Olszewski, Magdalena Sitnik, Maciej Bara, Positive impact of tranexamic acid in various medical settings , Prospects in Pharmaceutical Sciences: Vol. 22 No. 3 (2024)
Rafifah Azzahra, Helmi Arifin, Dian Ayu Juwita, The effect of ethyl acetate fraction of Vernonia amygdalina Del. leaves on uric acid levels of male white mice (Mus musculus) hyperuricemia , Prospects in Pharmaceutical Sciences: Vol. 22 No. 4 (2024)
Sükrü Canpolat, Cihan Düşgün, Elif Ildız, Elif Yürümez Canpolat, Cemil İşlek, Antioxidant potential and fatty acid composition of Lactarius sanguifluus , Prospects in Pharmaceutical Sciences: Vol. 22 No. 4 (2024)
Jakub Iwaszczuk, Aneta Baj, Piotr Wałejko, Sialic acids – structure and properties , Prospects in Pharmaceutical Sciences: Vol. 22 No. 4 (2024)
Aneta Emilia Jabłońska, Krzysztof Adam Stępień, COUNTERFEITING OF MEDICINAL PRODUCTS AND THREATS ASSOCIATED WITH THEIR TAKING , Prospects in Pharmaceutical Sciences: Vol. 17 No. 11 (2019)
Ewelina Flegiel, Magdalena Piotrowska, Magdalena Ptasznik, Aleksandra Baran, Justyna Lenart, Miłosz Podrażka, Joanna Mazurek, Hubert Stachowicz, Weronika Bartos, Monika Adamczyk, Review of the effects of sodium butyrate on obesity, inflammatory bowel disease, pregnancy and colorectal cancer , Prospects in Pharmaceutical Sciences: Vol. 22 No. 4 (2024)

1 2 3 4 5 > >>

You may also start an advanced similarity search for this article.

Details

References

Statistics

Authors

Download files

PDF (Język Polski)

Citation rules

Białek, A., & Tokarz, A. (2009). DIETARY SOURCES AND BENEFICIAL HEALTH EFFECTS OF CONJUGATED LINOLEIC ACIDS (CLA). Prospects in Pharmaceutical Sciences, 7(1), 1–12. https://doi.org/10.56782/pps.61

Altmetric indicators

Cited by / Share

Licence

This work is licensed under a Creative Commons Attribution 4.0 International License.

References

Farmakologia. Podstawy farmakoterapii. red. Kostowski W., Wyd. II poprawione, Wydawnictwo Lekarskie PZWL, Warszawa 2001; 234.

Obiedziński M.W., Bartnikowska E., Grześkiewicz S.: Występowanie sprzężonych dienów kwasu linolowego w produktach żywnościowych. Sympozjum „Olej z nasion wiesiołka i inne oleje, zawierające kwasy tłuszczowe n-6 lub n-3 w profilaktyce i terapii”, 1998; 47-52.

Turpeinen A.M., Mutagen M., Aro A. et al.: Bioconversion of Vaccenic Acid to Conjugated Linoleic Acid in Humans. Am. J. Clin. Nutr., 2002; 76:504-510. DOI: https://doi.org/10.1093/ajcn/76.3.504

Mosley E.E., Mc Guire M.K., Williams J.E., Mc Guide M.A.: Cis-9, trans-11 Conjugated Linoleic Acid Is Synthesized from Vaccenic Acid in Lactating Women. J. Nutr., 2006; 136:2297-2301. DOI: https://doi.org/10.1093/jn/136.9.2297

Pariza M.W., Park Y., Cook M.E.: The biologically active isomers of conjugated linoleic acid, Progress In Lipid Research, 2001; 40:283-293. DOI: https://doi.org/10.1016/S0163-7827(01)00008-X

Pariza M.W., Asheer S.H., Chu I.S., Lund D.H.: Effects of temperature and time on mutagen formation in pan-fried hamburger. Cancer Lett., 1979; 7:63-9. DOI: https://doi.org/10.1016/S0304-3835(79)80097-X

Pariza M.W., Hargraves W.A.: A beef-derived mutagenesis modulator inhibits initiation of mouse epidermal tumors by 7,12-dimethylbenz[a]anthracene. Carcinogenesis, 1985; 6:591-593. DOI: https://doi.org/10.1093/carcin/6.4.591

Masso-Welch P.A., Zangani D., Ip C., Vaughan M.M., Shoemaker S., Ramirez R.A., Ip. M.M: Inhibition of Angiogenesis by the Cancer Chemopreventive Agent Conjugated Linoleic Acid, Caner Res., 2002; 62: 4383-4389.

Pryor M., Slattery M.L., Robinson L.M., Egger M: Adolescent diet and breast cancer in Utah, Cancer Res., 1989; 49: 2161-2167.

Frazie A.L., Ryan C.T., Rockett H., Willett W.C., Colditz G.A.: Adolescent diet and risk of breast cancer, Breast Cancer Res., 2003; 5: R59-R64. DOI: https://doi.org/10.1186/bcr583

Thompson H., Zhu Z.J., Banni S., Darcy K., Lotus T., Ip C.: Morphological and biochemical status of the mammary gland as influenced by conjugated linoleic acid: implication for a reduction in mammary cancer risk, Cancer Res., 1997; 57: 5067-5072.

National Research Council (NRC): Carcinogens and Anticarcinogens in the Human Diet, National Academy Press, Washington DC, 1996

Munday J.S., Thompson K.G., James A.C.: Dietary conjugated linoleic acids promote fatty streak formation in the C57BL/6 mouse atherosclerosis model. Br. J. Nutr., 1999; 81:251-255. DOI: https://doi.org/10.1017/S0007114599000458

Nestel P., Fujii A., Allen T.: The cis-9,trans-11 isomer of conjugated linoleic acid (CLA) lowers plasma triglyceride and raises HDL cholesterol concentration but does not suppress aortic atherosclerosis in diabetic apoE-deficient mice. Atherosclerosis, 2006; 189:282-287. DOI: https://doi.org/10.1016/j.atherosclerosis.2005.12.020

Toomey S., Harhen B., Roche H.M. et al.: Profound resolution of early atherosclerosis with conjugated linoleic acid. Atherosclerosis, 2006; 187:40-49. DOI: https://doi.org/10.1016/j.atherosclerosis.2005.08.024

Arbonés-Mainar J.M., Navarro M.A., Guzmán M.A. et al.: Selective effect of conjugated linoleic acid isomers on atherosclerotic lesion development in apolipoprotein E knockout mice. Atherosclerosis, 2006; 189:318-327. DOI: https://doi.org/10.1016/j.atherosclerosis.2006.01.015

Kritchevsky D., Tepper S.A., Wright S. et al.: Influence of Conjugated Linoleic Acid (CLA) on Establishment and Progression of Atherosclerosis in Rabbits. J. Am. Coll. Nutr., 2000; 19(4):472S-477S. DOI: https://doi.org/10.1080/07315724.2000.10718950

Kritchevsky D., Tepper S.A., Wright S., Czarnecki S.K.: Influence of graded levels of conjugated linoleic acid (CLA) on experimental atherosclerosis in rabbits. Nutr. Res., 2002; 22:1275-1279. DOI: https://doi.org/10.1016/S0271-5317(02)00432-3

Kritchevsky D., Tepper S.A., Wright S. et al.: Conjugated Linoleic Acid Isomer Effects in Atherosclerosis: Growth and Regression of Lesions. Lipids, 2004; 39:611-616. DOI: https://doi.org/10.1007/s11745-004-1273-8

Nagao K., Inoue N., Wang Y.-M. et al.: The 10trans,12cis isomer of conjugated linoleic acid suppress the development of hypertension in Otsuka Long-Evans Tokushima fatty rats. Biochem. Biophys. Res. Commun., 2003; 306:134-138. DOI: https://doi.org/10.1016/S0006-291X(03)00929-X

Inoue N., Nagao K., Hirata J. et al.: Conjugated linoleic acid prevents the development of essential hypertension in spontaneously hypertensive rats. Biochem. Biophys. Res. Commun., 2004; 323:679-684. DOI: https://doi.org/10.1016/j.bbrc.2004.08.139

Deckere E.A.M., van Amelsvoort J.M.M., Neill G.P., Jones P.: Effects of conjugated linoleic acid (CLA) isomers on lipid levels and peroxisome proliferation in the hamster. Br. J. Nutr., 1999; 82:309-317. DOI: https://doi.org/10.1017/S0007114599001518

Gavino V.C., Gavio G., Leblanc M.-J. Tuchweber B.: An isomeric Mixture of Conjugated Linoleic Acids But Not Pure cis-9,trans-11-Octadecadienoic Acid Affects Body Weight gain and Plasma Lipids in Hamsters. J. Nutr., 2000; 130:27-29. DOI: https://doi.org/10.1093/jn/130.1.27

Navarro V., Zabala A., Macarulla M.T. et al.: Effects of conjugated linoleic acid on body fat accumulation and serum lipids in hamsters fed an atherogenic diet. J. Physiol. Biochem., 2003; 59(3):193-200. DOI: https://doi.org/10.1007/BF03179915

Valeille K., Gripois D., Bloquit M.-F. et al.: Lipid atherogenic risk markers can be more favorably influenced by the cis-9,trans-11-octadecadienoate isomer than a conjugated linoleic acid mixture or fish oil in hamsters. Br. J. Nutr., 2004; 91:191-199. DOI: https://doi.org/10.1079/BJN20031057

Lock A.L., Horne C.A.M., Bauman D.E., Salter A.M.: Butter Naturally Enriched in Conjugated Linoleic Acid and Vaccenic Acid Alters Tissue Fatty Acids and Improves the Plasma Lipoprotein Profile in Cholesterol-Fed Hamsters. J. Nutr., 2005; 135:1934-1939. DOI: https://doi.org/10.1093/jn/135.8.1934

Valeille K., Férézou J., Amsler G. et al.: A cis-9,trans-11-conjugated Linoleic acid-rich oil reduces the outcome of atherogenic process in hyperlipidemic hamster. Am. J. Physiol. Heart Circ. Physiol., 2005; 289:H652-H659. DOI: https://doi.org/10.1152/ajpheart.00130.2005

Valeille K., Férézou J., Parquet M. et al.: The Natural Concentration of the Conjugated Linoleic Acid, cis-9,trans-11, in Milk Fat Has Antiatherogenic Effects in Hyperlipidemic Hamster. J. Nutr., 2006; 136:1305-1310. DOI: https://doi.org/10.1093/jn/136.5.1305

Mitchell P.L., Langille M.A., Currie D.L., McLeod R.S.: Effect of conjugated linoleic acid isomers on lipoproteins and atherosclerosis in the Syrian Golden hamster. Biochim. Biophys. Acta, 2005; 1734:269-276. DOI: https://doi.org/10.1016/j.bbalip.2005.04.007

Wilson T.A., Nicolosi R.J., Saati A. et al.: Conjugated Linoleic Acid Isomers Reduce Blood Cholesterol Levels but Not Aortic Cholesterol Accumulation in Hypercholesterolemic Hamster. Lipids, 2006; 41:41-48. DOI: https://doi.org/10.1007/s11745-006-5068-8

Navarro V., Macarulla M.T., Fernández-Quintela A. et al.: Effects of trans-10,cis-12 conjugated Linoleic acid on cholesterol metabolism in hypercholesterolaemic hamsters. Eur. J. Nutr., 2007; 46:213-219. DOI: https://doi.org/10.1007/s00394-007-0653-z

Moya-Camarena S.Y., Belury M.A.: Species Differences in the Metabolism and Regulation of Gene Expression by Conjugated Linoleic Acid. Nutr. Rev., 1999; 57(11):336-340. DOI: https://doi.org/10.1111/j.1753-4887.1999.tb06910.x

Biochemia Harpera. Wyd. V, Wydawnictwo Lekarskie PZWL, Warszawa 2004; 354.

Mougios V., Matsakas A., Petridou A. et al.: Effect of supplementation with conjugated linoleic acid on human serum lipids and body fat. J. Nutr. Biochem., 2001; 12:585-594. DOI: https://doi.org/10.1016/S0955-2863(01)00177-2

Tricon S., Burge G.C., Kew S. et al.: Opposing effects of cis-9,trans-11 and trans-10,cis-12 conjugated linoleic acid on blood lipids in healthy humans. Am. J. Clin. Nutr., 2004; 80:614-620. DOI: https://doi.org/10.1093/ajcn/80.3.614

Tricon S., Burge G.C., Jones E.L. et al.: Effects of diary products naturally enriched with cis-9,trans-11 conjugated linoleic acid on the blood profile in healthy middle-aged men. Am. J. Clin. Nutr., 2006; 83:744-753. DOI: https://doi.org/10.1093/ajcn/83.4.744

Risérus U., Smedman A., Basu S., Vessby B.: Metabolic effects of conjugated linoleic acid in humans: the Swedish experience. Am. J. Clin. Nutr., 2004; 79:1146S-1148S. DOI: https://doi.org/10.1093/ajcn/79.6.1146S

Moloney F., Yeow T.-P., Mullen A. et al.: Conjugated linoleic acid supplementation, insulin sensitivity, and lipoprotein metabolism in patient with type 2 diabetes mellitus. Am. J. Clin. Nutr., 2004; 80:887-895. DOI: https://doi.org/10.1093/ajcn/80.4.887

Taylor J.S.W., Williams S.R.P., Rhys R. et al.: Conjugated Linoleic Acid Impairs Endothelial Function. Arterioscler. Thromb. Vasc. Biol., 2006; 26:307-312. DOI: https://doi.org/10.1161/01.ATV.0000199679.40501.ac

Tokarz A., Białek A., Stawarska A., Gołębiowska L.: Porównanie zawartości sprzężonych dienów kwasu linolowego – CLA w masłach dostępnych na rynku warszawskim w 2006 roku. Żywienie człowieka i metabolizm, 2007; 1/2:118-127.

Tokarz A., Białek A., Krasowska M.: Ocena zawartości kwasu żwaczowego (cis-9, trans-11 CLA) w wybranych gatunkach serów. Bromat. Chem. Toksykol., 2008; 3: 580–584.

Precht D., Molketin J.: Analysis and seasonal variation of conjugated linoleic acid and further cis-/trans- isomers of C18:1 and C18:2 in bovine milk fat, Kieler Milchwirtschaftliche Forschungsberichte, 1999; 51:63-78.

Ledoux M., Chardigny J. - M., Darbois M., Soustre Y., SebedioJ. - L., Laloux L.: Fatty acid composition of French butters, with special emphasis on conjugated linoleic acid (CLA) isomers, J. Food Comp. Anal., 2005; 18:409–425. DOI: https://doi.org/10.1016/j.jfca.2004.01.001

Jensen R.G.: The Composition of Bovine Milk Lipids: January 1995 to December 2000, J. Dairy Sci., 2002; 85:295–302. DOI: https://doi.org/10.3168/jds.S0022-0302(02)74079-4

Tanaka K.: Occurrence of conjugated linoleic acid in ruminant products and its physiological functions, Animal Science Journal, 2005; 76:291-303. DOI: https://doi.org/10.1111/j.1740-0929.2005.00268.x

Sieber R., Collomb M., Aeschlimann A., Jelen P., Eyer H.: Impact of microbal cultures on conjugated linoleic acid in dairy products – a review. International Dairy Journal, 2004; 14:1-15. DOI: https://doi.org/10.1016/S0958-6946(03)00151-1

Lavillonniere F., Martin J. C., Bougnoux P., Sebedio J.-L.: Analysis of Conjugated Linoleic Acid and Content in French Cheeses. JAOCS, 1998; 75, 3:343-352. DOI: https://doi.org/10.1007/s11746-998-0051-6

Zlatanos S., Laskaridis K., Feist C., Sagredos A.: CLA content and fatty acid composition of Greek Feta and hard cheeses. Food Chemistry, 2002; 78:471-477. DOI: https://doi.org/10.1016/S0308-8146(02)00159-0

McGuire M. A., McGuire M. K.: Conjugated linoleic acid (CLA): A ruminant fatty acid with beneficial effects on human health. Proceeding of the American Society of Animal Science, 1999; http://www.asas.org/symposia/9899proc/0938.pdf. DOI: https://doi.org/10.2527/jas2000.00218812007700ES0033x

Agnieszka Białek

Affiliation:

Katedra i Zakład Bromatologii Wydział Farmaceutyczny, Warszawski Uniwersytet Medyczny Poland

Andrzej Tokarz

Affiliation:

Katedra i Zakład Bromatologii Wydział Farmaceutyczny, Warszawski Uniwersytet Medyczny Poland